Avadel Pharmaceuticals (AVDL) Change in Accured Expenses (2016 - 2022)
Historic Change in Accured Expenses for Avadel Pharmaceuticals (AVDL) over the last 8 years, with Q4 2022 value amounting to -$4.0 million.
- Avadel Pharmaceuticals' Change in Accured Expenses fell 16539.97% to -$4.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $227000.0, marking a year-over-year decrease of 7463.69%. This contributed to the annual value of $16.4 million for FY2024, which is 277.05% down from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Change in Accured Expenses of -$4.0 million as of Q4 2022, which was down 16539.97% from $1.7 million recorded in Q3 2022.
- In the past 5 years, Avadel Pharmaceuticals' Change in Accured Expenses registered a high of $3.3 million during Q2 2021, and its lowest value of -$6.6 million during Q4 2020.
- In the last 5 years, Avadel Pharmaceuticals' Change in Accured Expenses had a median value of -$640500.0 in 2021 and averaged -$1.1 million.
- Per our database at Business Quant, Avadel Pharmaceuticals' Change in Accured Expenses plummeted by 34126.46% in 2020 and then skyrocketed by 33487.54% in 2021.
- Avadel Pharmaceuticals' Change in Accured Expenses (Quarter) stood at $1.0 million in 2018, then skyrocketed by 168.24% to $2.7 million in 2019, then tumbled by 341.26% to -$6.6 million in 2020, then soared by 76.88% to -$1.5 million in 2021, then plummeted by 165.4% to -$4.0 million in 2022.
- Its Change in Accured Expenses was -$4.0 million in Q4 2022, compared to $1.7 million in Q3 2022 and $245000.0 in Q2 2022.